Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

NRW Holdings Happily Says Goodbye To FY25

Aug 27 2025

After a rough FY25 beset with many issues beyond the company’s control, mining contractor NRW Holdings looks forward to a solid FY26


Universal Store Bucking the Trend

Aug 26 2025

In a tough consumer environment, youth fashion retailer Universal Store continues to post exceptional sales and margins. A slight earnings miss reflects investment in future growth


Can Virgin Succeed This Time?

Jul 23 2025

Three Brokers initiating coverage of a resurrected Virgin Australia compare Australia’s second airline to arch-rival Qantas


Partnerships Enhance Atturra’s Digital Prowess

Jul 22 2025

New research on IT services group Atturra points to shares trading at a discount to valuation despite sustained organic growth supported by strategic partnerships and acquisitions


Legacy Business Fuels Kinatico’s SaaS Ambition

Jul 16 2025

As Kinatico transitions to a new compliance SaaS solution, the legacy business provides funding for the new service development and a pool of potential customers


Market Embraces Hansen’s Powercloud Surprise

Jul 16 2025

After a shaky start, Hansen Technologies’ powercloud acquisition has turned the corner, delivering a positive surprise to analysts and investors


SRG Global: Building Australia

Jul 10 2025

In just about any infrastructure sector one could name, SRG Global is involved through its many recurring maintenance, engineering and construction contracts, and analysts see nothing but solid growth ahead


ikeGPS Positioned For Multi-Decade Tailwinds

Jul 08 2025

Sales of ikeGPS Group’s suite of products are benefitting from structural trends. New research explains these tools remain critical for a range of large customers, with the current focus on North America


Tasmea’s Secret Sauce For Higher-Margin Growth

Jul 07 2025

New research illustrates Tasmea’s high margins derive from a unique operating model, small acquisitions and cross-selling between subsidiaries


The Enigma Surrounding Clinuvel

Jul 03 2025

Clinuvel Pharmaceuticals posted a strong first half result, and offers significant upside in expanding the use of its flagship drug, but investors just aren’t excited



Analyse The Market From A Different Angle